Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies Virtual London Healthcare Conference (
Nov. 17, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Managements Presents at Cowen Virtual Presentation Series 20
Nov. 13, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Management at Credit Suisse 29th Annual Virtual Healthcare C
Nov. 10, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Dr. Leonard Schleifer on Q3 2020 Results - Earnings Call
Nov. 6, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Management at Cantor Fitzgerald Virtual Global Healthcare Co
Sept. 15, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Morgan Stanley 18th Annual Global Hea
Sept. 14, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Presents at Citi's 15th Annual BioPharma Virtual Conference
Sept. 9, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q2 2020 Results - Earnings Call Tra
Aug. 5, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Presents At BMO 2020 Prescriptions for Success Healthcare Conferen
June 23, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Credit Suisse Biotech Management & Bo
June 22, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference (Tra
June 2, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer Presents at Bernstein's 36th Annual Strate
May 30, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q1 2020 Earnings Call Transcript
May 6, 2020 | Price: Free! | Source: Motley Fool

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2020 Results - Earnings Call Tra
May 5, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q4 2019 Earnings Call Transcript
Feb. 6, 2020 | Price: Free! | Source: Motley Fool

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q4 2019 Results - Earnings Call Tra
Feb. 6, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer on 38th Annual J.P. Morgan Healthcare Conf
Jan. 13, 2020 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Piper Jaffray 31st Annual Healthcare
Dec. 3, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc.'s (REGN) Management Presents at Jefferies London Healthcare Confere
Nov. 20, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q3 2019 Earnings Call Transcript
Nov. 5, 2019 | Price: Free! | Source: Motley Fool

Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer on Q3 2019 Results - Earnings Call Transcr
Nov. 5, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q2 2019 Earnings Call Transcript
Aug. 6, 2019 | Price: Free! | Source: Motley Fool

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q2 2019 Results - Earnings Call Tra
Aug. 6, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2019 Results - Earnings Call Tra
May 7, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) J.P. Morgan 2019 Spring Biotech Conference (Transcript)
March 15, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Presents at Cowen Health Care Broker Conference Call (Transc
March 11, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q4 2018 Results - Earnings Call Tra
Feb. 6, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer Presents at 37th Annual J.P. Morgan He
Jan. 8, 2019 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer Presents at Piper Jaffray 30th Annual
Nov. 27, 2018 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q3 2018 Results - Earnings Call Transcript
Nov. 6, 2018 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q1 2018 Results - Earnings Call Transcript
May 3, 2018 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q4 2017 Results - Earnings Call Transcript
Feb. 8, 2018 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q3 2017 Results - Earnings Call Transcript
Nov. 8, 2017 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q2 2017 Results - Earnings Call Transcript
Aug. 3, 2017 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q1 2017 Results - Earnings Call Transcript
May 4, 2017 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q4 2016 Results - Earnings Call Transcri
Feb. 9, 2017 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q3 2016 Results - Earnings Call Transcri
Nov. 4, 2016 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Leonard S. Schleifer, M.D., Ph.D. on Q2 2016 Results - Earnings Ca
Aug. 4, 2016 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Earnings Report: Q1 2016 Conference Call Transcript
May 6, 2016 | Price: Free! | Source: The Street

Regeneron Pharmaceuticals (REGN) Leonard S. Schleifer on Q1 2016 Results - Earnings Call Transcript
May 5, 2016 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Earnings Report: Q4 2015 Conference Call Transcript
Feb. 9, 2016 | Price: Free! | Source: The Street

Regeneron Pharmaceuticals (REGN) Q4 2015 Results - Earnings Call Webcast
Feb. 9, 2016 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q4 2015 Results - Earnings Call Transcri
Feb. 9, 2016 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Leonard S. Schleifer, M.D., Ph.D. on Q3 2015 Results - Earnings Ca
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Earnings Report: Q3 2015 Conference Call Transcript
Nov. 4, 2015 | Price: Free! | Source: The Street

Regeneron Pharmaceuticals (REGN) Q3 2015 Results - Earnings Call Webcast
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Earnings Report: Q2 2015 Conference Call Transcript
Aug. 4, 2015 | Price: Free! | Source: The Street

Regeneron Pharmaceuticals (REGN) Leonard S. Schleifer, M.D., Ph.D. on Q2 2015 Results - Earnings Ca
Aug. 4, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Earnings Report: Q1 2015 Conference Call Transcript
May 7, 2015 | Price: Free! | Source: The Street

Regeneron Pharmaceuticals (REGN) Leonard S. Schleifer, M.D., Ph.D. on Q1 2015 Results - Earnings Ca
May 7, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q1 2015 Results - Earnings Call Webcast
May 7, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q4 2014 Results - Earnings Call Webcast
Feb. 10, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q4 2014 Results - Earnings Call Transcript
Feb. 10, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Earnings Report: Q4 2014 Conference Call Transcript
Feb. 10, 2015 | Price: Free! | Source: The Street

Regeneron Pharmaceuticals (REGN) Q2 2015 Results - Earnings Call Webcast
Feb. 4, 2015 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q3 2014 Results - Earnings Call Transcri
Nov. 4, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q3 2014 Results - Earnings Call Webcast
Nov. 4, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q2 2014 Results - Earnings Call Transcri
Aug. 5, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals (REGN) Q2 2014 Results - Earnings Call Webcast
Aug. 5, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q1 2014 Results - Earnings Call Transcri
May 8, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. Q4 2013
Feb. 11, 2014 | Price: Free! | Source: Morningstar

Q4 2013 Regeneron Pharmaceutica Earnings Conference call (Webcast)
Feb. 11, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 11, 2014 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. - J. P. Morgan Healthcare Conference Transcript
Jan. 14, 2014 | Price: Free! | Source: Earnings Impact

Regeneron Pharmaceuticals at Oppenheimer Healthcare Conference Transcript
Dec. 11, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. - Oppenheimer 24th Annual Healthcare Conference Transcript
Dec. 11, 2013 | Price: Free! | Source: Earnings Impact

Regeneron Pharmaceuticals' Management Presents at Oppenheimer & Co. Inc. 24th Annual Healthcare Con
Dec. 11, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals Management Presents at Piper Jaffray Healthcare Conference (Transcript)
Dec. 3, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Piper Jaffray Healthcare Conference Transcript
Dec. 3, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals' CEO Presents at Deutsche Bank 2013 BioFEST Conference (Transcript)
Dec. 2, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. - 2013 Deutsche Bank BioFEST Conference Transcript
Dec. 2, 2013 | Price: Free! | Source: Earnings Impact

Regeneron Pharmaceuticals at Deutsche Bank BioFEST Conference Transcript
Dec. 2, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Credit Suisse Healthcare Conference Transcript
Nov. 12, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Q3 2013
Nov. 6, 2013 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals Q3 2013 Earnings Conference Call Transcript
Nov. 5, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. - Q3 2013 Earnings Call Transcript
Nov. 5, 2013 | Price: Free! | Source: Earnings Impact

Regeneron Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 5, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals Conference Call to Discuss Phase 3 Data for EYLEA Injection in Diabetic M
Sept. 28, 2013 | Price: $54.00 | Source: Thomson

Regeneron Pharmaceuticals at Robert W Baird and Co Health Care Conference Transcript
Sept. 10, 2013 | Price: $54.00 | Source: Thomson

Regeneron Pharmaceuticals at Morgan Stanley Healthcare Conference Transcript
Sept. 9, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals' Management Presents at Morgan Stanley Global Healthcare Conference (Tran
Sept. 9, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. - Q2 2013 Earnings Call Transcript
Aug. 6, 2013 | Price: Free! | Source: Earnings Impact

Regeneron Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 6, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc. Q2 2013
Aug. 6, 2013 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals Inc (REGN) Management Discusses Q2 2013 Results (Webcast)
Aug. 6, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals Q2 2013 Earnings Conference Call Transcript
Aug. 6, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference,
June 11, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Goldman Sachs Healthcare Conference Transcript
June 11, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Jefferies Global Healthcare Conference Transcript
June 3, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Presents at 38th Annual Deutsche Bank Health Care Conference, May-2
May 29, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Deutsche Bank dbAccess Health Care Conference Transcript
May 29, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at UBS Global Healthcare Conference Transcript
May 20, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 10:00 AM
May 20, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Robert W Baird and Co Growth Stock Conference Transcript
May 8, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
May 3, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc.(REGN) Q1 2013 Earnings Call Transcript
May 3, 2013 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals Q1 2013 Earnings Conference Call Transcript
May 3, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2013 02:3
March 12, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Barclays Healthcare Conference Transcript
March 12, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at RBC Capital Markets\' Healthcare Conference Transcript
Feb. 27, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Presents at Citi 2013 Global Healthcare Conference, Feb-26-2013 01:
Feb. 26, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Citi Global Healthcare Conference Transcript
Feb. 26, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals Q4 2012 Earnings Conference Call Transcript
Feb. 14, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals, Inc. Q4 2012
Feb. 14, 2013 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Feb. 14, 2013 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at JPMorgan Global Healthcare Conference Transcript
Jan. 8, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conferen
Jan. 3, 2013 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Deutsche Bank dbAccess BioFEST Transcript
Dec. 3, 2012 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Piper Jaffray Healthcare Conference Transcript
Nov. 28, 2012 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals' CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 14, 2012 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals at Credit Suisse Group AG Healthcare Conference Transcript
Nov. 14, 2012 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at Lazard Capital Markets Healthcare Conference Transcript
Nov. 13, 2012 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals CEO Discusses Q3 2012 Results - Earnings Call Transcript
Oct. 24, 2012 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc.(REGN) Q3 2012 Earnings Call Transcript
Oct. 24, 2012 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals Q3 2012 Earnings Conference Call Transcript
Oct. 24, 2012 | Price: $106.00 | Source: Thomson

Regeneron Pharmaceuticals at UBS Global Life Sciences Conference Transcript
Sept. 20, 2012 | Price: $54.00 | Source: Thomson

Regeneron Pharmaceuticals at Morgan Stanley Healthcare Conference Transcript
Sept. 11, 2012 | Price: $54.00 | Source: Thomson

Regeneron Pharmaceuticals at Robert W Baird\'s Health Care Conference Transcript
Sept. 5, 2012 | Price: $54.00 | Source: Thomson

Regeneron Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
July 25, 2012 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc.(REGN) Q2 2012 Earnings Call Transcript
July 25, 2012 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals, Inc.(REGN) Q1 2012 Earnings Call Transcript
April 26, 2012 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
April 26, 2012 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb. 13, 2012 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals, Inc.(REGN) Q4 2011 Earnings Call Transcript
Feb. 13, 2012 | Price: Free! | Source: Morningstar

Regeneron Pharmaceuticals' CEO Presents at the JPMorgan Global Healthcare Conference (Transcript)
Jan. 9, 2012 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals' CEO Presents at the 2011 Deutsche Bank BioFEST - Conference Call Transcr
Dec. 5, 2011 | Price: Free! | Source: Seeking Alpha

Regeneron Pharmaceuticals Management Hosts Credit Suisse Annual Healthcare Conference - Conference
Nov. 9, 2011 | Price: Free! | Source: Seeking Alpha

Recent filings

Regeneron Pharmaceuticals's EVP Research just cashed-in 13,736 options - Nov. 18, 2020

Regeneron Pharmaceuticals director just picked up 11 shares - Nov. 13, 2020

Regeneron Pharmaceuticals director just disposed of 4,600 shares - Nov. 3, 2020

Regeneron Pharmaceuticals's EVP Research just picked up 5,185 shares - Oct. 23, 2020

Regeneron Pharmaceuticals's SVP Commercial just cashed-in 2,000 options - Oct. 6, 2020

Regeneron Pharmaceuticals director just cashed-in 9,212 options - Oct. 6, 2020

Regeneron Pharmaceuticals director just disposed of 100 shares - Oct. 5, 2020

Regeneron Pharmaceuticals director just cashed-in 16,574 options - Sept. 23, 2020

Regeneron Pharmaceuticals director just disposed of 2,000 shares - Sept. 23, 2020

Regeneron Pharmaceuticals director just disposed of 100 shares - Sept. 3, 2020

Regeneron Pharmaceuticals director just disposed of 10,000 shares - Aug. 31, 2020

Regeneron Pharmaceuticals director just cashed-in 40,000 options - Aug. 31, 2020

Regeneron Pharmaceuticals's EVP General Counsel and Secret just cashed-in 10,000 options - Aug. 31, 2020

Regeneron Pharmaceuticals director just disposed of 21,000 shares - Aug. 27, 2020

Regeneron Pharmaceuticals's EVP & General Mgr Industrial O just disposed of 27,109 shares - Aug. 27, 2020

Regeneron Pharmaceuticals director just declared owning 6,250 shares of Regeneron Pharmaceuticals - Aug. 24, 2020

Regeneron Pharmaceuticals director just disposed of 31,000 shares - Aug. 24, 2020

Regeneron Pharmaceuticals's EVP & General Mgr Industrial O just picked up 27,109 shares - Aug. 24, 2020

Regeneron Pharmaceuticals director just disposed of 1,000 shares - Aug. 24, 2020

Entry into a Material Definitive - Aug. 19, 2020

Regeneron Pharmaceuticals director just disposed of 106,901 shares - Aug. 13, 2020

Creation of a Direct Financial Obligation or an Obligation under an - Aug. 12, 2020

Regeneron Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 11, 2020

Regeneron Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 7, 2020

Filing under Securities Act Rules 163/433 of free writing prospectuses - Aug. 7, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just disposed of 696 shares - Aug. 5, 2020

Regeneron Pharmaceuticals director just disposed of 100 shares - Aug. 5, 2020

Regeneron Reports Second Quarter 2020 Financial And Operating Results - Aug. 5, 2020

Regeneron Pharmaceuticals Just Filed Its Quarterly Report: Net Income Per Share... - Aug. 5, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just picked up 696 shares - July 22, 2020

Regeneron Pharmaceuticals's VP Controller just picked up 2,224 shares - July 22, 2020

Regeneron Pharmaceuticals's EVP Research just disposed of 2,380 shares - July 15, 2020

Regeneron Pharmaceuticals's EVP Research just disposed of 5,620 shares - July 15, 2020

Confidential treatment order - July 15, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just disposed of 579 shares - July 14, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just picked up 579 shares - July 13, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 12,500 options - July 9, 2020

Regeneron Pharmaceuticals director just cashed-in 1,706 options - July 8, 2020

Regeneron Pharmaceuticals director just disposed of 3,000 shares - July 8, 2020

Entry into a Material Definitive - July 7, 2020

Regeneron Pharmaceuticals director just cashed-in 3,613 options - July 2, 2020

Regeneron Pharmaceuticals director just disposed of 100 shares - July 2, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just disposed of 400 shares - June 30, 2020

Regeneron Pharmaceuticals director just disposed of 3,000 shares - June 29, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 8,900 options - June 24, 2020

Regeneron Pharmaceuticals director just cashed-in 2,559 options - June 22, 2020

Regeneron Pharmaceuticals's VP Controller just picked up 2,180 shares - June 17, 2020

Sanofi just provided an update on activist position in Regeneron Pharmaceuticals - June 17, 2020

Departure of Directors or Certain - June 16, 2020

Securities to be offered to employees in employee benefit plans - June 16, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 3,500 options - June 12, 2020

Regeneron Pharmaceuticals director just cashed-in 3,412 options - June 12, 2020

Regeneron Pharmaceuticals insider just disposed of 120,234 shares - June 11, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 15,500 options - June 10, 2020

Statement of acquisition of beneficial ownership by individuals - June 10, 2020

Regeneron Pharmaceuticals director just cashed-in 10,838 options - June 9, 2020

Regeneron: Form, Schedule Or Registration Statement No Filing Party: Dated Filed: REGENERON PHARMACEUTICALS, INC. - June 8, 2020

Regeneron Pharmaceuticals director just cashed-in 2,559 options - June 5, 2020

Regeneron Pharmaceuticals director just disposed of 100 shares - June 2, 2020

Regeneron Pharmaceuticals director just disposed of 1,000 shares - June 1, 2020

Regeneron Pharmaceuticals director just disposed of 2,000 shares - June 1, 2020

Sanofi just provided an update on activist position in Regeneron Pharmaceuticals - May 29, 2020

Regeneron Pharmaceuticals insider just disposed of 22,821,451 shares - May 29, 2020

On May - May 29, 2020

Regeneron Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 28, 2020

Regeneron Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 26, 2020

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 26, 2020

Regeneron Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 26, 2020

Regeneron Pharmaceuticals's Chairman of the Board just disposed of 1,780 shares - May 22, 2020

Regeneron Pharmaceuticals's Chairman of the Board just picked up 4,047 shares - May 22, 2020

Regeneron Pharmaceuticals's EVP General Counsel and Secret just cashed-in 18,311 options - May 15, 2020

Regeneron Pharmaceuticals director just disposed of 850 shares - May 13, 2020

Regeneron Pharmaceuticals's President & CEO just cashed-in 312,500 options - May 13, 2020

Regeneron Pharmaceuticals's EVP Research and Development just cashed-in 12,500 options - May 11, 2020

Regeneron Pharmaceuticals director just cashed-in 15,000 options - May 8, 2020

Regeneron Pharmaceuticals director just cashed-in 5,118 options - May 8, 2020

Regeneron Pharmaceuticals's EVP & General Mgr Industrial O just cashed-in 85,579 options - May 8, 2020

Regeneron Pharmaceuticals director just cashed-in 5,470 options - May 7, 2020

Regeneron Pharmaceuticals director just cashed-in 50,124 options - May 7, 2020

Regeneron Pharmaceuticals director just disposed of 2,000 shares - May 6, 2020

Regeneron Reports First Quarter 2020 Financial And Operating Results - May 5, 2020

Regeneron Pharmaceuticals Just Filed Its Quarterly Report: Net Income Per Share... - May 5, 2020

Regeneron Pharmaceuticals director just disposed of 100 shares - May 4, 2020

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 24, 2020

Regeneron: Form, Schedule Or Registration Statement No Filing Party: Dated Filed: - April 24, 2020

Regeneron Pharmaceuticals releases salary data. CEO sees compensation fall -19% - April 24, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 16,500 options - April 20, 2020

Regeneron Pharmaceuticals's EVP General Counsel and Secret just picked up 1,778 shares - April 20, 2020

Regeneron Pharmaceuticals's EVP General Counsel and Secret just disposed of 1,778 shares - April 20, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 3,500 options - April 16, 2020

Regeneron Pharmaceuticals's EVP General Counsel and Secret just cashed-in 5,000 options - April 16, 2020

Regeneron Pharmaceuticals's EVP Research and Development just cashed-in 13,079 options - April 15, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 3,500 options - April 13, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just cashed-in 3,000 options - April 8, 2020

Entry into a Material Definitive - April 7, 2020

Regeneron Pharmaceuticals's VP Controller just cashed-in 1,200 options - April 3, 2020

Regeneron Pharmaceuticals's EVP General Counsel and Secret just cashed-in 15,000 options - April 3, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just picked up 188 shares - April 3, 2020

Regeneron Pharmaceuticals's EVP Finance CFO just disposed of 788 shares - April 3, 2020

Regeneron Pharmaceuticals director just disposed of 200 shares - April 1, 2020

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. FMR LLC 8,464,310 N/A March 31, 2020
2. FMR LLC 8,464,310 N/A March 31, 2020
3. FMR LLC 8,464,310 N/A March 31, 2020
4. VANGUARD GROUP INC 6,079,347 N/A June 30, 2019
5. Sanofi 4,785,593 N/A Dec. 31, 2015
6. State Street Corp 4,551,665 N/A June 30, 2020
7. State Street Corp 4,551,665 N/A June 30, 2020
8. State Street Corp 3,617,333 0.1 March 31, 2020
9. LOOMIS SAYLES & CO L P 3,259,698 1.7 June 30, 2020
10. FMR LLC 3,225,827 N/A Dec. 31, 2019
11. BlackRock Fund Advisors 2,290,395 0.1 Sept. 30, 2016
12. WELLINGTON MANAGEMENT CO LLP 2,056,759 N/A March 31, 2020
13. BlackRock Institutional Trust Company, N.A. 2,037,231 0.1 Dec. 31, 2016
14. POLEN CAPITAL MANAGEMENT LLC 1,844,534 3.4 June 30, 2020
15. Nuveen Asset Management, LLC 1,706,789 0.2 June 30, 2020
16. BANK OF AMERICA CORP /DE/ 1,638,662 N/A Sept. 30, 2017
17. ALLIANCEBERNSTEIN L.P. 1,542,746 0.5 June 30, 2020
18. GEODE CAPITAL MANAGEMENT, LLC 1,521,133 N/A June 30, 2020
19. SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,435,669 N/A Dec. 31, 2019
20. Invesco Ltd. 1,344,273 N/A June 30, 2019
21. GEODE CAPITAL MANAGEMENT, LLC 1,332,517 0.2 March 31, 2020
22. JANUS CAPITAL MANAGEMENT LLC 1,317,162 0.3 March 31, 2017
23. NORTHERN TRUST CORP 916,314 N/A March 31, 2018
24. AMERICAN CENTURY COMPANIES INC 898,471 0.5 June 30, 2020
25. RENAISSANCE TECHNOLOGIES LLC 890,100 0.5 June 30, 2020
26. SANDS CAPITAL MANAGEMENT, LLC 839,415 1.2 June 30, 2020
27. CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 837,998 0.5 June 30, 2020
28. NORGES BANK 816,880 0.1 June 30, 2019
29. FRANKLIN RESOURCES INC 693,744 N/A June 30, 2020
30. Legal & General Group Plc 692,428 N/A June 30, 2020
Regeneron Announces Investor Conference Presentations - Nov. 13, 2020

Regeneron Announces Investor Conference Presentations - Oct. 27, 2020

Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN) - Oct. 21, 2020

Haeggquist & Eck, LLP Is Investigating Claims Against Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty - Oct. 8, 2020

Regeneron to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2020 - Oct. 6, 2020

Kaskela Law LLC Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) and Encourages Long-Term REGN Stockholders to Contact the Firm - Sept. 5, 2020

Regeneron Announces Investor Conference Presentations - Aug. 26, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals Inc. - Aug. 19, 2020

Regeneron Announces Pricing of Public Offering of Senior Unsecured Notes - Aug. 7, 2020

ALERT: Rowley Law PLLC is Investigating Potential Breaches of Fiduciary Duty by Officers and Directors of Regeneron Pharmaceuticals, Inc. - Aug. 3, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals Inc. - July 31, 2020

Kaskela Law LLC Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) and Encourages Long-Term REGN Stockholders to Contact the Firm - July 23, 2020

Regeneron to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2020 - July 8, 2020

Regeneron Announces Manufacturing and Supply Agreement for BARDA and U.S. Department of Defense for REGN-COV2 Anti-Viral Antibody Cocktail - July 7, 2020

 


Feedback